MedPath

AZACITIDINE FOR INJECTION

AZACITIDINE FOR INJECTION

Approved
DIN Number

02529599

Drug Class

Human

Market Date

Apr 17, 2023

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02529599
AIG Number0152665001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01BC07 AZACITIDINE
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AZACITIDINEActive
Strength: 100 MG / VIAL
Monograph: AZACITIDINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.